NO20040880L - Casein avledete peptider og anvendelser derav i terapi. - Google Patents

Casein avledete peptider og anvendelser derav i terapi.

Info

Publication number: NO20040880L
Authority: NO; Norway
Prior art keywords: casein; therapy; applications; derived peptides; peptides
Prior art date: 2001-08-30

Application number

NO20040880A

Other languages

English (en)

Norwegian (no)

Inventor

Zvi Sidelman

Original Assignee

Chay 13 Medical Res Group Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-30

Filing date

2004-02-27

Publication date

2004-04-20

2001-08-30 Priority claimed from US09/942,121 external-priority patent/US20020147144A1/en

2004-02-27 Application filed by Chay 13 Medical Res Group Nv filed Critical Chay 13 Medical Res Group Nv

2004-04-20 Publication of NO20040880L publication Critical patent/NO20040880L/no

Links

239000005018 casein Substances 0.000 title 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title 1
235000021240 caseins Nutrition 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
238000002560 therapeutic procedure Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Virology (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Zoology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
AIDS & HIV (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Emergency Medicine (AREA)
Marine Sciences & Fisheries (AREA)
Tropical Medicine & Parasitology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO20040880A 2001-08-30 2004-02-27 Casein avledete peptider og anvendelser derav i terapi. NO20040880L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/942,121 US20020147144A1 (en)	2000-03-01	2001-08-30	Casein derived peptides and uses thereof in therapy
PCT/IL2002/000720 WO2003018606A2 (en)	2001-08-30	2002-08-29	Casein derived peptides and uses thereof in therapy

Publications (1)

Publication Number	Publication Date
NO20040880L true NO20040880L (no)	2004-04-20

Family

ID=25477603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040880A NO20040880L (no)	2001-08-30	2004-02-27	Casein avledete peptider og anvendelser derav i terapi.

Country Status (15)

Country	Link
EP (1)	EP1556074A4 (pl)
JP (1)	JP2005511499A (pl)
KR (1)	KR20040078639A (pl)
CN (1)	CN1694719A (pl)
AU (1)	AU2002324323A2 (pl)
BR (1)	BR0212625A (pl)
CA (1)	CA2458924A1 (pl)
CZ (1)	CZ2004335A3 (pl)
HU (1)	HUP0500995A3 (pl)
IL (1)	IL160548A0 (pl)
MX (1)	MXPA04001890A (pl)
NO (1)	NO20040880L (pl)
PL (1)	PL375113A1 (pl)
WO (1)	WO2003018606A2 (pl)
ZA (1)	ZA200401574B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0313892D0 (en) *	2003-06-16	2003-07-23	Hannah Res Inst	Control of lactation
US20050192312A1 (en) *	2004-01-30	2005-09-01	Brown Dennis M.	Naphthalimide dosing by N-acetyl transferase genotyping
KR20070007128A (ko) *	2004-03-01	2007-01-12	펩테라 파마슈티컬스 엘티디.	카제인 파생 펩타이드들과 그의 치료적 사용들
GB0423352D0 (en) *	2004-10-21	2004-11-24	Hannah Res Inst	"Control of mammary cell number"
ES2319475B1 (es) *	2005-06-08	2010-02-16	Consejo Superior Investig. Cientificas	Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
EP2030629B1 (en) *	2006-06-09	2014-04-30	Morinaga Milk Industry Co., Ltd.	Alpha-s-casein as lipid-metabolism-improving agent
JP2011026213A (ja) *	2009-07-22	2011-02-10	Snow Brand Milk Prod Co Ltd	１型糖尿病抑制ペプチド
AU2013249522A1 (en) *	2012-04-16	2014-10-30	The Cleveland Clinic Foundation	Multivalent breast cancer vaccine
EP3590519A4 (en) *	2017-03-03	2020-12-16	Morinaga Milk Industry Co., Ltd.	GLP-1 SECRETAGOGUE AND COMPOSITION
CN107814835B (zh) *	2017-12-01	2020-04-28	熊猫乳品集团股份有限公司	一种生物活性多肽avpitptlnreq及其制备方法和应用
CN108017709B (zh) *	2017-12-12	2020-04-10	浙江辉肽生命健康科技有限公司	一种生物活性多肽kepmigvnqela及其制备方法和应用
CN113952446B (zh) *	2021-09-03	2023-12-05	河南省医药科学研究院	生物活性肽在抑制骨髓毒性中的应用
CN120815163B (zh) *	2025-09-16	2025-12-12	华中科技大学同济医学院附属同济医院	能抑制ccnb2表达的抗肿瘤药物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3778426A (en) *	1970-12-16	1973-12-11	Research Corp	Therapeutically useful polypeptides
US6150547A (en) *	1997-03-21	2000-11-21	Snow Brand Milk Products Co., Ltd.	Iron-casein complex hydrolyzate and process for the production thereof
IL134830A0 (en) *	2000-03-01	2001-05-20	Chay 13 Medical Res Group N V	Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them

2002
- 2002-08-29 HU HU0500995A patent/HUP0500995A3/hu unknown
- 2002-08-29 AU AU2002324323A patent/AU2002324323A2/en not_active Abandoned
- 2002-08-29 KR KR10-2004-7002884A patent/KR20040078639A/ko not_active Withdrawn
- 2002-08-29 CZ CZ2004335A patent/CZ2004335A3/cs unknown
- 2002-08-29 CN CNA028216741A patent/CN1694719A/zh active Pending
- 2002-08-29 EP EP02758768A patent/EP1556074A4/en not_active Withdrawn
- 2002-08-29 BR BRPI0212625-7A patent/BR0212625A/pt not_active IP Right Cessation
- 2002-08-29 MX MXPA04001890A patent/MXPA04001890A/es not_active Application Discontinuation
- 2002-08-29 CA CA002458924A patent/CA2458924A1/en not_active Abandoned
- 2002-08-29 PL PL02375113A patent/PL375113A1/pl not_active Application Discontinuation
- 2002-08-29 IL IL16054802A patent/IL160548A0/xx unknown
- 2002-08-29 WO PCT/IL2002/000720 patent/WO2003018606A2/en not_active Ceased
- 2002-08-29 JP JP2003523265A patent/JP2005511499A/ja active Pending
2004
- 2004-02-26 ZA ZA200401574A patent/ZA200401574B/en unknown
- 2004-02-27 NO NO20040880A patent/NO20040880L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1694719A (zh)	2005-11-09
CA2458924A1 (en)	2003-03-06
KR20040078639A (ko)	2004-09-10
CZ2004335A3 (cs)	2004-07-14
EP1556074A4 (en)	2008-05-07
EP1556074A2 (en)	2005-07-27
IL160548A0 (en)	2004-07-25
JP2005511499A (ja)	2005-04-28
MXPA04001890A (es)	2004-06-18
BR0212625A (pt)	2007-06-19
WO2003018606A9 (en)	2004-04-08
WO2003018606A3 (en)	2005-05-06
WO2003018606A2 (en)	2003-03-06
HUP0500995A3 (en)	2008-09-29
ZA200401574B (en)	2007-02-28
HUP0500995A2 (en)	2007-05-02
AU2002324323A2 (en)	2003-03-10
PL375113A1 (pl)	2005-11-28

Legal Events

Date	Code	Title	Description
2009-03-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1641822T3 (da)	2013-07-22	Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
HUP0301003A3 (en)	2007-08-28	Casein derived peptides and uses thereof in therapy
NO20040246L (no)	2004-04-01	TACI'er- og BR3-polypeptider og anvendelser derav
IS2662B (is)	2010-08-15	Mótefni sem blokka prótínið Cripto og notkun þeirra
DK1680443T3 (da)	2013-12-16	Stabiliserede alfa-helix-peptider og anvendelser heraf
EP1461605A4 (en)	2009-10-21	NANOSTERIALS OF PROTEINS AND PEPTIDES
NO20034962D0 (no)	2003-11-07	Beta-amyloid peptid-bindende proteiner og polynukleotider som koder for samme
DK1462455T3 (da)	2013-07-01	Ser-Ser-Ser-Arg-peptid samt medicinske anvendelser deraf
EP1419175A4 (en)	2006-07-19	PEPTIDES OF REPLIKIN AND THEIR USE
HUP0500995A2 (en)	2007-05-02	Casein derived peptides and uses thereof in therapy
NO20020919L (no)	2002-04-25	Irenprotein, dets fremstilling og anvendelse
NO20005547L (no)	2001-01-02	Myelinbasisproteinpeptider og anvendelser derav
EP1411964A4 (en)	2006-06-14	THE BLOOD GENERATING PEPTIDES AND THEIR USES
EP1389126A4 (en)	2006-06-28	RETROCYCLINE: ANTIVIRAL AND ANTIMICROBIAL PEPTIDES
NO20012030L (no)	2002-10-28	Kryptografisk signering i små enheter
PT1140803E (pt)	2004-03-31	(aminoiminometil)amino)alcanocarboxamidas e suas aplicacoes em terapia
CY1105287T1 (el)	2010-03-03	Ορχεως - ειδικη ανθρωπινη svph1-8 πρωτεϊναση
IL153740A0 (en)	2003-07-06	Grf2-binding proteins and applications thereof
EP1395674A4 (en)	2005-04-20	ISOLATED HUMAN PROTEASE PROTEINS, HUMAN PROTEASE PROTEIN CODING NUCLEIC ACID MOLECULES AND USES THEREOF
AU2003303464A8 (en)	2004-07-22	Centrosome-associated protein and applications thereof
DE10045123B8 (de)	2008-01-24	Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein
DK1897945T3 (da)	2012-05-07	IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
AU8557801A (en)	2002-03-13	Modified proteins, isolated novel peptides, and uses thereof
NO20024029D0 (no)	2002-08-23	Nytt protein og gen som koder for proteinet
AU8748101A (en)	2001-12-24	A novel polypeptide, a human protein stat2 and the polynucleotide encoding the polypeptide